FDA Announces Draft Guidance for Manufacturers to Notify Agency of Device Discontinuance or Interruption

Summary

The Food and Drug Administration (FDA) has released a draft guidance for manufacturers to notify the agency of permanent discontinuance or interruption in manufacturing of certain medical devices, aimed at preventing or mitigating shortages during public health emergencies.